Prices

Controlling Health Care Costs

Striking the Right Balance Between Lowering U.S. Prescription Drug Prices and Preserving Incentives for Innovation

Journal Article / Dec 02, 2020

Controlling Health Care Costs

What Can Be Done to Improve All-Payer Claims Databases?

Blog / Oct 23, 2020

Controlling Health Care Costs

Health Care in the 2020 Presidential Election: Commercial Health Care Costs

Blog / Oct 12, 2020

Controlling Health Care Costs

Health Care in the 2020 Presidential Election: Prescription Drugs

Blog / Oct 07, 2020

Controlling Health Care Costs

Getting to Lower Prescription Drug Prices: The Key Drivers of Costs and What Policymakers Can Do to Address Them

Fund Reports / Oct 01, 2020

Controlling Health Care Costs

Catastrophic Coverage in the Medicare Part D Drug Benefit: Which Beneficiaries Need It and How Much Are They Spending?

Issue Briefs / Sep 17, 2020

Controlling Health Care Costs

Drug Pricing and Pandemic Preparedness in the 2022 FDA User Fee Reauthorization Process

Blog / Jul 23, 2020

Improving Health Care Quality

COVID-19 Highlights Problems with Our Generic Supply Chain

Blog / May 07, 2020

Achieving Universal Coverage

Supreme Court Tells Government to “Honor its Obligations” to ACA Insurers

Blog / May 04, 2020

Controlling Health Care Costs

The Elijah E. Cummings Lower Drug Costs Now Act: How It Would Work, How It Would Affect Prices, and What the Challenges Are

Issue Briefs / Apr 09, 2020

Controlling Health Care Costs

Drug Price Moderation in Germany: Lessons for U.S. Reform Efforts

Issue Briefs / Jan 23, 2020

Controlling Health Care Costs

The Role of Private Equity in Driving Up Health Care Prices

Blog / Oct 29, 2019